Purchase Order 36C24825P0474

Award Date 12/27/24
Potential Completion Date 1/10/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Memphis, TN 38141, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $20,624.40, was issued by the Department of Veterans Affairs (VA) to Mckesson Corporation, a healthcare services and IT company, for the provision of HUMATIN 250MG pharmaceuticals. The award is structured as a firm fixed price purchase order with a completion date of November 29, 2024. Mckesson, the prime contractor, has previously provided a range of pharmaceutical products and services to various federal agencies, including the Department of Justice's...
The federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency, to the prime contractor Mckesson Corporation for the provision of HUMATIN 250 MG pharmaceutical products. The firm fixed-price purchase order has a ceiling value of $11,859.00 and an ultimate completion date of April 25, 2025. The contract does not have a set-aside designation. Mckesson Corporation, a prominent healthcare services and IT company, has a strong presence in federal...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs to McKesson Corporation, a large healthcare services and IT company, for the delivery of HUMATIN USP CAPS 250MG 100 EMERGENCY pharmaceutical products. The $11,859 contract has a completion date of June 30, 2025 and does not utilize any set-aside designations. McKesson Corporation is the prime contractor, and the contract supports the Department of Veterans Affairs' healthcare programs and medical...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to McKesson Specialty Health Pharmaceutical & Biotech Solutions LLC, a subsidiary of McKesson Corporation. The contract is for the delivery of HUMATIN USP CAPS 250MG pharmaceutical products, with a ceiling value of $23,718.00 and an ultimate completion date of June 27, 2025. The contract was not set aside for any specific business type. McKesson Corporation is a large, for-profit...
The Department of Veterans Affairs awarded a firm fixed price purchase order to Mckesson Corporation, doing business as Mckesson, for the supply of HUMATIN (PAROMOMYCIN) 250MG. The contract has a ceiling value of $11,859.00 and an ultimate completion date of January 13, 2025. This award was not set aside for any specific business type. Mckesson is a healthcare services and IT company that provides pharmaceuticals, medical supplies, and healthcare solutions to government agencies. The company has...
This firm fixed-price purchase order for $10,312.20 was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 to Mckesson Corporation, a healthcare services and IT company, for the delivery of "EMERGENCY HUMATIN" by August 24, 2024. The contract does not have a set-aside designation. Mckesson is the prime contractor and does not have any major subcontractors identified. The VA has utilized Mckesson as a prime contractor through various...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a firm fixed price purchase order contract to Mckesson Specialty Care Distribution LLC, a subsidiary of Mckesson Corporation, for the delivery of "EMERGENCY HUMATIN" with a potential value of $10,312.20 and a completion date of May 17, 2024. This contract was issued by the VA-VHA's Veterans Integrated Service Network 7 without any set-aside designation. Mckesson is a major healthcare services and...
This is a $10,312.20 firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 20 to Mckesson Corporation, a healthcare services and IT company, for the provision of HUMATIN EMERGENT products. The contract has a completion date of July 10, 2024 and does not utilize a set-aside designation. This contract award appears to be part of Mckesson's broader work as a prime contractor providing pharmaceuticals, medical supplies, and healthcare IT...
This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 8 to the prime contractor Mckesson Corporation, doing business as Mckesson, to provide Paromomycin 250mg HUMATIN pharmaceuticals. The contract has a ceiling value of $10,312.20 and a completion date of September 27, 2024. Mckesson is a healthcare services and information technology company that provides pharmaceuticals, medical supplies, and healthcare IT solutions...
This is a firm fixed price purchase order awarded to Mckesson Corporation, doing business as Mckesson, by the Department of Veterans Affairs' Veterans Integrated Service Network 7. The award, valued at $10,312.20, is for the emergency purchase of Humitan medication. No set-aside was used. Mckesson is a healthcare services and information technology company that has provided a range of pharmaceutical products and services to various federal agencies through multiple contract vehicles, including...

This federal contract award was made by the Department of Veterans Affairs (VA) to McKesson Corporation, a major supplier of pharmaceutical products and services to the U.S. government. The $11,859.00 firm-fixed-price purchase order is for the delivery of HUMATIN 250 MG, an emergency pharmaceutical order. The contract supports healthcare services provided at VA medical centers across the VA's Veterans Integrated Service Network 8 (VISN 8). McKesson holds two significant federal contracts with the VA and General Services Administration (GSA) that enable the company to provide a wide range of pharmaceutical products to various government agencies, including the VA and Bureau of Prisons. This contract award does not have a set-aside designation, indicating McKesson's status as a large, established contractor in the federal pharmaceutical supply chain.

Generated 12/28/24, 9:21 AM